We identified a number of promising associations that have strong biological plausibility, including NCK1, NCAPH2 and L3MBTL4. A contemporaneous analysis also used ASSET across a number of different non-BCM cancers, and discovered a novel risk locus at 1q22 involving breast and lung cancer59. This evidence concerns the gene L3MBTL4 and cancer.